Brecanavir
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Brecanavir (
INN; codenamed GW640385) is a protease inhibitor which has been studied for the treatment of HIV.[1]
In December 2006, its developer,
GlaxoSmithKline discontinued further development because of insurmountable issues regarding formulation.[2]
See also
References
- PMID 17620375.
- ^
"GlaxoSmithKline discontinues clinical development of investigational protease inhibitor brecanavir (640385)" (Press release). GlaxoSmithKline. 2006-12-18. Archived from the originalon 2008-12-03. Retrieved 2008-06-11.